Efavirenz + emtricitabine + tenofovir: new com... [Prescrire Int. 2009] - PubMed

Save items

loading

Related citations in PubMed

Efavirenz/emtricitabine/tenofovir disoproxil fumarate: triple combination tablet. [Drugs. 2006]
Efavirenz/emtricitabine/tenofovir disoproxil fumarate: triple combination tablet.
Frampton JE, Croom KF. Drugs. 2006; 66(11):1501-12; discussion 1513-4.
[One year with Atripla. Changeover to complete HIV therapy in a single tablet has proven successful]. [MMW Fortschr Med. 2009]
[One year with Atripla. Changeover to complete HIV therapy in a single tablet has proven successful].
Warpakowski A. MMW Fortschr Med. 2009 Apr 30; 151(18):54-5.
Recent availability of two novel, fixed formulations of antiretroviral nucleoside analogues: a 12-month prospective, open-label survey of their practical use and therapeutic perspectives in antiretroviral-naive and -experienced patients. [AIDS Patient Care STDS. 2008]
Recent availability of two novel, fixed formulations of antiretroviral nucleoside analogues: a 12-month prospective, open-label survey of their practical use and therapeutic perspectives in antiretroviral-naive and -experienced patients.
Manfredi R, Calza L. AIDS Patient Care STDS. 2008 Apr; 22(4):279-90.
Review Efavirenz/emtricitabine/tenofovir disoproxil fumarate fixed-dose combination: first-line therapy for all? [Expert Opin Pharmacother. 2007]
Review Efavirenz/emtricitabine/tenofovir disoproxil fumarate fixed-dose combination: first-line therapy for all?
Goicoechea M, Best B. Expert Opin Pharmacother. 2007 Feb; 8(3):371-82.
Review The first once-daily single-tablet regimen for the treatment of HIV-infected patients. [Drugs Today (Barc). 2007]
Review The first once-daily single-tablet regimen for the treatment of HIV-infected patients.
Killingley B, Pozniak A. Drugs Today (Barc). 2007 Jul; 43(7):427-42.

See reviews... See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Compound (MeSH Keyword)
PubChem chemical compound records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.

Recent activity

Clear Turn Off Turn On

Efavirenz + emtricitabine + tenofovir: new combination. HIV infection: do not mo...
Efavirenz + emtricitabine + tenofovir: new combination. HIV infection: do not modify ongoing therapy just to use one less tablet. Better adherence than with separate dosing has not been demonstrated, while reduced efficacy is plausible.
Prescrire Int. 2009 Jun ;18(101):105.

PubMed
Dabigatran: new drug. Continue to use heparin, a better-known option.
Dabigatran: new drug. Continue to use heparin, a better-known option.
Prescrire Int. 2009 Jun ;18(101):97-9.

PubMed
Neural networks and synaptic transmission in immature hippocampus.
Neural networks and synaptic transmission in immature hippocampus.
Adv Exp Med Biol. 1990 ;268:161-71.

PubMed
Antibacterial coatings on titanium implants.
Antibacterial coatings on titanium implants.
J Biomed Mater Res B Appl Biomater. 2009 Oct ;91(1):470-80.

PubMed
Transport by SLC5A8 with subsequent inhibition of histone deacetylase 1 (HDAC1) ...
Transport by SLC5A8 with subsequent inhibition of histone deacetylase 1 (HDAC1) and HDAC3 underlies the antitumor activity of 3-bromopyruvate.
Cancer. 2009 Oct 15 ;115(20):4655-66.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to:

Efavirenz + emtricitabine + tenofovir: new combination. HIV infection: do not modify ongoing therapy just to use one less tablet. Better adherence than with separate dosing has not been demonstrated, while reduced efficacy is plausible.

MeSH Terms, Substances

MeSH Terms

Substances

LinkOut - more resources

Medical

Supplemental Content

Save items

Related citations in PubMed

Related information

Recent activity

Simple NCBI Directory

Getting Started

Resources

Popular

Featured

NCBI Information